ArticleJournal of translational medicine2026
Unraveling the regulatory role of intercellular communication in intestinal immune cells mediated by H₂ in sepsis recovery through single-cell RNA sequencing.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundSepsis is a life-threatening condition with dysregulated immune responses, where the intestinal immune system plays a pivotal role. While hydrogen gas (H₂) has shown therapeutic potential, its precise impact on intestinal immune cell communication remains elusive.
methodsWe employed a murine model of sepsis induced by cecal ligation and puncture (CLP). Mice were divided into control, sepsis, and H₂-treated sepsis groups. A comprehensive approach combining single-cell RNA sequencing (scRNA-seq) of intestinal tissues with histological, biochemical, and functional analyses was used to dissect the immune landscape and H₂'s effects.
resultsH₂ treatment significantly ameliorated intestinal injury, reduced epithelial barrier leakage (evidenced by decreased serum DAO and FITC-dextran), and suppressed systemic inflammation. scRNA-seq revealed that H₂ restored sepsis-induced perturbations in both B and T cell subsets. It normalized the aberrant expansion of non-functional B cells and rectified T cell differentiation trajectories, promoting a functional balance. Mechanistically, H₂ modulated key genes (e.g., Stat3, Ccl5, Foxo1) and critical pathways including oxidative phosphorylation, B cell receptor signaling, and Foxo signaling. Furthermore, cell-cell communication analysis demonstrated that H₂ robustly enhanced the weakened interactions between T cells, B cells, and epithelial cells, particularly via the CCL signaling network.
conclusionOur study elucidates that H₂ therapy alleviates sepsis by systemically reprogramming the intestinal immune micro environment at the single-cell level. This is achieved by normalizing immune cell subsets, rewiring intercellular communication, and ultimately rebalancing the inflammatory response, positioning H₂ as a promising immunomodulatory agent for sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.